FLSmidth A/S
Company Announcement No. 4-2021:
On Wednesday 24 March 2021 at 4 PM (CET), FLSmidth & Co. A/S held its Annual General Meeting as a completely electronic meeting with the following agenda:
- The Board of Directors' report on the company’s activities in 2020
- Presentation and approval of the Annual Report 2020
- Approval of the Board of Directors’ fees
- Final approval of fees for 2020
- Preliminary approval of fees for 2021
- Distribution of profits or covering of losses in accordance with the approved Annual Report
- Presentation of the Remuneration Report 2020 for an advisory vote
- Election of members to the Board of Directors
- Election of company auditor
- Proposals from the Board of Directors
- Amendment of the articles of association – renewal of the Board of Directors’ authorisations to increase the company’s share capital
- Amendment of the articles of association – authorisation to the Board of Directors to decide to hold general meetings partially or fully by electronic means
- Treasury shares
- Amendment of the articles of association – renewal of the Board of Directors’ authorisations to increase the company’s share capital
- Proposal from shareholders AkademikerPension and LD Fonde
- Any other business
------------------------------------------
Re 1: The General Meeting took note of the Board of Directors' report.
Re 2: The General Meeting approved the Annual Report 2020.
Re 3: Approval of Board of Directors' fees:
a: The General Meeting approved the Board of Directors' fees for 2020.
b: The General Meeting approved the preliminary determination of fees for 2021.
Re. 4: The Board of Directors' proposal regarding distribution of dividends was adopted.
Re 5: The Remuneration Report 2020 was approved by advisory vote.
Re 6: The General Meeting re-elected Mr. Vagn Ove Sørensen, Mr. Tom Knutzen, Mr. Richard Robinson Smith (Rob Smith), Ms. Anne Louise Eberhard, Ms. Gillian Dawn Winckler and Mr. Thrasyvoulos Moraitis to the Board of Directors.
Also, an employee election meeting had been held at which Leif Gundtoft, Claus Østergaard and Carsten Hansen were elected employee representatives for the Group. Bodil Recke, Jens Peter Koch and Søren Quistgaard were elected alternates.
Re 7: The General Meeting adopted the proposal by the Board of Directors to reappoint EY Godkendt Revisionspartnerselskab as auditor in accordance with the recommendation from the Audit Committee.
Re 8.1: Amendment of the articles of association – renewal of the Board of Directors’ authorisations to increase the company’s share capital - was approved. The authorisation is thereby extended until 24 March 2026 with a total aggregate issue of new shares of DKK 100,000,000.
Re 8.2: Amendment of the articles of association – authorisation to the Board of Directors to decide to hold general meetings partially or fully by electronic means was approved.
Re 8.3: The Board of Directors’ proposal to authorise the company to repurchase treasury shares until the next Annual General Meeting was approved.
Re 9: Proposal from shareholders AkademikerPension and LD Fonde to publish corporate country-by-country tax reporting in line with the Global Reporting Initiative’s standard (GRI 207: Tax 2019) starting from the financial year 2021 was approved.
The Chairman of the Annual General Meeting closed the Annual General Meeting at 17.08 (CET).
39.37 % of the votes were represented at the Annual General Meeting.
At the subsequent Board Meeting, the Board of Directors elected Mr. Vagn Ove Sørensen as Chairman and Mr. Tom Knutzen as Vice Chairman.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom